Reply to: "Comment on - A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in the Republic of Korea''

被引：0
作者：
Kim, Beom Kyung [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
[3] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 72卷 / 01期
关键词：
HEPATOCELLULAR-CARCINOMA; RISK;
D O I：
10.1016/j.jhep.2019.10.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：198 / 199
页数：3
相关论文
共 11 条
  • [1] RETRACTED: Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study (Retracted Article)
    Choi, Jonggi
    Kim, Hyo Jeong
    Lee, Jayoun
    Cho, Songhee
    Ko, Min Jung
    Lim, Young-Suk
    [J]. JAMA ONCOLOGY, 2019, 5 (01) : 30 - 36
  • [2] Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B One of These Things Is Not Like the Other
    Flemming, Jennifer A.
    Terrault, Norah A.
    [J]. JAMA ONCOLOGY, 2019, 5 (01) : 17 - 18
  • [3] Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
    Hanouneh, Ibrahim A.
    Alkhouri, Naim
    Singal, Amit G.
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (03) : 264 - 269
  • [4] A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
    Kim, Seung Up
    Seo, Yeon Seok
    Lee, Han Ah
    Kim, Mi Na
    Lee, Yu Rim
    Lee, Hye Won
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Hwang, Seong Gyu
    Rim, Kyu Sung
    Um, Soon Ho
    Tak, Won Young
    Kweon, Young Oh
    Kim, Beom Kyung
    Park, Soo Young
    [J]. JOURNAL OF HEPATOLOGY, 2019, 71 (03) : 456 - 464
  • [5] Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and liver-related events in patients with chronic hepatitis B: A propensity score analysis
    Lee, Sung Won
    Kwon, Jung Hyun
    Lee, Hae Lim
    Yoo, Sun Hong
    Nam, Hee Chul
    Sung, Pil Soo
    Nam, Soon Woo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Han, Nam Ik
    Jang, Jeong Won
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E472 - E472
  • [6] Unmet need in chronic hepatitis B management
    Liang, Lilian Yan
    Wong, Grace Lai-Hung
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (02) : 172 - 180
  • [7] Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other?
    Wong, Grace Lai-Hung
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2019, 71 (03) : 453 - 455
  • [8] Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
    Wong, Linda L.
    Reyes, Ruel J.
    Kwee, Sandi A.
    Hernandez, Brenda Y.
    Kalathil, Sumodh C.
    Tsai, Naoky C.
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (03) : 239 - 248
  • [9] KASL clinical practice guidelines for management of chronic hepatitis B
    Yim, Hyung Joon
    Kim, Ji Hoon
    Park, Jun Yong
    Yoon, Eileen L.
    Park, Hana
    Kwon, Jung Hyun
    Sinn, Dong Hyun
    Lee, Sae Hwan
    Lee, Jeong-Moon
    Lee, Hyun Woong
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2019, 25 (02) : 93 - 159
  • [10] Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B
    Yip, Terry C. F.
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Chan, Henry
    Wong, Grace Lai-Hung
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E128 - E128
12